166 related articles for article (PubMed ID: 19781947)
21. N-(4-Substituted-benzoyl)-N'-(β-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods.
Nagy V; Felföldi N; Kónya B; Praly JP; Docsa T; Gergely P; Chrysina ED; Tiraidis C; Kosmopoulou MN; Alexacou KM; Konstantakaki M; Leonidas DD; Zographos SE; Oikonomakos NG; Kozmon S; Tvaroška I; Somsák L
Bioorg Med Chem; 2012 Mar; 20(5):1801-16. PubMed ID: 22325154
[TBL] [Abstract][Full Text] [Related]
22. Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.
Oikonomakos NG; Tiraidis C; Leonidas DD; Zographos SE; Kristiansen M; Jessen CU; Nørskov-Lauritsen L; Agius L
J Med Chem; 2006 Sep; 49(19):5687-701. PubMed ID: 16970395
[TBL] [Abstract][Full Text] [Related]
23. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.
Oikonomakos NG; Tsitsanou KE; Zographos SE; Skamnaki VT; Goldmann S; Bischoff H
Protein Sci; 1999 Oct; 8(10):1930-45. PubMed ID: 10548038
[TBL] [Abstract][Full Text] [Related]
24. The σ-hole phenomenon of halogen atoms forms the structural basis of the strong inhibitory potency of C5 halogen substituted glucopyranosyl nucleosides towards glycogen phosphorylase b.
Kantsadi AL; Hayes JM; Manta S; Skamnaki VT; Kiritsis C; Psarra AM; Koutsogiannis Z; Dimopoulou A; Theofanous S; Nikoleousakos N; Zoumpoulakis P; Kontou M; Papadopoulos G; Zographos SE; Komiotis D; Leonidas DD
ChemMedChem; 2012 Apr; 7(4):722-32. PubMed ID: 22267166
[TBL] [Abstract][Full Text] [Related]
25. A New Potent Inhibitor of Glycogen Phosphorylase Reveals the Basicity of the Catalytic Site.
Mamais M; Degli Esposti A; Kouloumoundra V; Gustavsson T; Monti F; Venturini A; Chrysina ED; Markovitsi D; Gimisis T
Chemistry; 2017 Jul; 23(37):8800-8805. PubMed ID: 28493496
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory mode of indole-2-carboxamide derivatives against HLGPa: molecular docking and 3D-QSAR analyses.
Liu G; Zhang Z; Luo X; Shen J; Liu H; Shen X; Chen K; Jiang H
Bioorg Med Chem; 2004 Aug; 12(15):4147-57. PubMed ID: 15246091
[TBL] [Abstract][Full Text] [Related]
27. New synthesis of 3-(β-D-glucopyranosyl)-5-substituted-1,2,4-triazoles, nanomolar inhibitors of glycogen phosphorylase.
Kun S; Bokor É; Varga G; Szőcs B; Páhi A; Czifrák K; Tóth M; Juhász L; Docsa T; Gergely P; Somsák L
Eur J Med Chem; 2014 Apr; 76():567-79. PubMed ID: 24608000
[TBL] [Abstract][Full Text] [Related]
28. New pentacyclic triterpenes from Gypsophila oldhamiana and their biological evaluation as glycogen phosphorylase inhibitors.
Luo JG; Liu J; Kong LY
Chem Biodivers; 2008 May; 5(5):751-7. PubMed ID: 18493961
[TBL] [Abstract][Full Text] [Related]
29. 5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.
Wright SW; Rath VL; Genereux PE; Hageman DL; Levy CB; McClure LD; McCoid SC; McPherson RK; Schelhorn TM; Wilder DE; Zavadoski WJ; Gibbs EM; Treadway JL
Bioorg Med Chem Lett; 2005 Jan; 15(2):459-65. PubMed ID: 15603973
[TBL] [Abstract][Full Text] [Related]
30. Dissecting the catalytic mechanism of a plant beta-D-glucan glucohydrolase through structural biology using inhibitors and substrate analogues.
Hrmova M; Fincher GB
Carbohydr Res; 2007 Sep; 342(12-13):1613-23. PubMed ID: 17548065
[TBL] [Abstract][Full Text] [Related]
31. FlexE: efficient molecular docking considering protein structure variations.
Claussen H; Buning C; Rarey M; Lengauer T
J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
[TBL] [Abstract][Full Text] [Related]
32. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.
Wen X; Sun H; Liu J; Cheng K; Zhang P; Zhang L; Hao J; Zhang L; Ni P; Zographos SE; Leonidas DD; Alexacou KM; Gimisis T; Hayes JM; Oikonomakos NG
J Med Chem; 2008 Jun; 51(12):3540-54. PubMed ID: 18517260
[TBL] [Abstract][Full Text] [Related]
33. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
Perola E; Walters WP; Charifson PS
Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
[TBL] [Abstract][Full Text] [Related]
34. A new type of five-membered heterocyclic inhibitors of basic metallocarboxypeptidases.
Fernández D; Avilés FX; Vendrell J
Eur J Med Chem; 2009 Aug; 44(8):3266-71. PubMed ID: 19386397
[TBL] [Abstract][Full Text] [Related]
35. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
36. Crystallographic studies on N-azidoacetyl-beta-D-glucopyranosylamine, an inhibitor of glycogen phosphorylase: comparison with N-acetyl-beta-D-glucopyranosylamine.
Petsalakis EI; Chrysina ED; Tiraidis C; Hadjiloi T; Leonidas DD; Oikonomakos NG; Aich U; Varghese B; Loganathan D
Bioorg Med Chem; 2006 Aug; 14(15):5316-24. PubMed ID: 16616506
[TBL] [Abstract][Full Text] [Related]
37. Glucose-based spiro-oxathiazoles as in vivo anti-hyperglycemic agents through glycogen phosphorylase inhibition.
Goyard D; Kónya B; Czifrák K; Larini P; Demontrond F; Leroy J; Balzarin S; Tournier M; Tousch D; Petit P; Duret C; Maurel P; Docsa T; Gergely P; Somsák L; Praly JP; Azay-Milhau J; Vidal S
Org Biomol Chem; 2020 Feb; 18(5):931-940. PubMed ID: 31922157
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of docking programs for predicting binding of Golgi alpha-mannosidase II inhibitors: a comparison with crystallography.
Englebienne P; Fiaux H; Kuntz DA; Corbeil CR; Gerber-Lemaire S; Rose DR; Moitessier N
Proteins; 2007 Oct; 69(1):160-76. PubMed ID: 17557336
[TBL] [Abstract][Full Text] [Related]
39. Quantitative structure-based design: formalism and application of receptor-dependent RD-4D-QSAR analysis to a set of glucose analogue inhibitors of glycogen phosphorylase.
Pan D; Tseng Y; Hopfinger AJ
J Chem Inf Comput Sci; 2003; 43(5):1591-607. PubMed ID: 14502494
[TBL] [Abstract][Full Text] [Related]
40. Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core.
Rath VL; Ammirati M; LeMotte PK; Fennell KF; Mansour MN; Danley DE; Hynes TR; Schulte GK; Wasilko DJ; Pandit J
Mol Cell; 2000 Jul; 6(1):139-48. PubMed ID: 10949035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]